New Report From the Global Coalition on Aging Highlights the Connection Between Adult Immunization and Economic Health in Aging APEC Region

The report, released as government and business leaders come together for APEC Economic Leaders’ Week, calls for targeted actions to meet both health and economic goals for the region.

New York, NEW YORK (November 9, 2023) – As leaders from across the Asia-Pacific Economic Cooperation (APEC) region convene in San Francisco over the next week, a new report from the Global Coalition on Aging (GCOA) points to investments in healthy aging as a growing economic imperative amid the region’s changing demographics. According to the new report, programs that keep populations healthy, active, and productive – like adult immunization – are increasingly becoming a prerequisite for economic stability and growth.

“An estimated 630 million people over the age of 60 live in APEC economies, which are at the leading edge of a global demographic shift,” said Mike Hodin, CEO of the Global Coalition on Aging. “As the region ages, leaders are recognizing the impact of investments in healthy aging on economic productivity and sustainability,” said Hodin.

The new GCOA report highlights adult immunization programs, in particular, as an important opportunity for APEC economies to invest in healthy aging, given the dual connection between immunization and increased workforce participation and economic activity on one side and decreased healthcare system utilization and spending, on the other.

APEC economies have already taken steps to prioritize immunization for adults, notably through the introduction, in 2021, of a 10-year Action Plan on Vaccination Across the Life-Course and last year’s launch of a dashboard to measure progress. Yet, more than two years in, the economies have shown variable commitment to the Action Plan. In order to realize the Action Plan, all APEC economies should be committing to national immunization program across the life course with clear recommendations for implementation.

The GCOA report draws on data from across the APEC economies, including newly published research from the International Longevity Centre-Singapore, a Tsao Foundation initiative, which highlights the need for APEC leaders to strengthen their existing immunization efforts through widespread awareness-raising at the community level and leveraging existing resources within communities to better reach older adults.

As APEC leaders look to ensure continued economic growth and both fiscal and health system sustainability, the GCOA report outlines four key action areas to support these goals:

  1. Prioritize prevention for older adults, including through robust national immunization programs to increase vaccine uptake.
  2. Invest in health education and awareness-raising for older adults and those they trust.
  3. Integrate immunization programs into community-based programs, resources, and health systems.
  4. Quantify the costs of vaccine-preventable diseases and the returns on investment in prevention and immunization to support evidence-based decisionmaking.

“We commend the valuable work that APEC leaders have initiated to strengthen immunization across the life course, while recognizing the need for more and targeted actions to build on this work,” said Mike Hodin, CEO of the Global Coalition on Aging. “Now, with even clearer evidence from the International Longevity Centre-Singapore and their latest research, we hope APEC leaders prioritize healthy longevity through impactful policies to help meet their adult immunization goals.

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

GCOA Sign-on Letter to Governor Spanberger: Consequences of Importing Federal Price Caps on Virginians’ Access to Medicine & Healthy Aging Opportunities

Dear Governor Spanberger: We, the undersigned organizations, bring deep, on‑the‑ground experience serving older Americans, patients managing complex and chronic conditions, and their caregivers across Virginia and nationwide. We also have a clear understanding of which policies and programs are effective and where they fall short.

New Report Summarizes State of Expert Opinions on Japan’s Adult Vaccine Policy as Population Shifts Older

The Global Coalition on Aging (GCOA), Health and Global Policy Institute (HGPI), and the Asia-Pacific Consortium for Healthy Aging and Adult Immunization (AP-CHAAI) today announced the launch of Strengthening Vaccine Policy for Healthy Aging and Economic Growth in Japan, a landscape analysis examining the state of vaccine policy in super-aging Japan. Based on a comprehensive review of over 100 policy documents, recommendations, reports, academic papers, and gray literature articles, the report, which was funded by GSK, summarizes the latest academic research and policy discourse around adult vaccines.

WSJ Letter to the Editor: How Flu Vaccine Policies Affect the Economy

Your editorial “Vinay Prasad’s Vaccine Kill Shot” (Review & Outlook, Feb. 12) points out that a recent decision by Mr. Prasad, the leader of the Food and Drug Administration’s vaccine division, will have negative consequences. Mr. Prasad’s decision to reject Moderna’s flu vaccine without even reviewing it is even worse than you describe. Denying us a new, innovative flu vaccine is horrible health policy. Innovation is at risk because, as Moderna’s CEO has said, if the largest market is off limits, investments won’t be made. But the decision will also have economic consequences. Investment in preventive health is critical as our population ages. In its April 2025 World Economic Outlook report, the International Monetary Fund dedicated an entire chapter to the need for healthier longevity as the global population ages.

Global Coalition on Aging, Leading G7 Government Officials, Call for Incentivized Antibiotic Innovation

The Global Coalition on Aging (GCOA), in partnership with the Japanese Pharmaceutical Manufacturer’s Association (JPMA), and public health leaders call on G7 governments to fund pull incentives and make “fair share” investments in antibiotic innovation to fight the global antimicrobial resistance (AMR) crisis. GCOA, JPMA, and health and government officials from the European Union, Italy, Japan, and United Kingdom recently convened to discuss how G7 countries must respond. GCOA today published a report detailing takeaways from the closed-door meeting, “The Role of G7 Governments in Global Efforts to Encourage Antimicrobial Development Through a Pull Incentive: Challenges and Collaboration.”

2024 AMR Preparedness Index Progress Report Highlights Urgent Need For Global Action Against Antimicrobial Resistance

Today, the Global Coalition on Aging (GCOA) and the Infectious Diseases Society of America (IDSA) launched the 2024 AMR Preparedness Index Progress Report. Released in the lead up to the United Nations General Assembly 2024 High-level Meeting on Antimicrobial Resistance (AMR) this September, the 2024 Progress Report assesses how the eleven largest global economies have advanced on calls to action laid out in the 2021 AMR Preparedness Index.

New Global Analysis Across Five Cities Shows Inequities in Adult Immunization Uptake, Signaling Need to Redesign Local and National Policy Interventions

GSK, in collaboration with the Global Coalition on Aging (GCOA), announced a new report from the IQVIA Institute for Human Data Science (IQVIA Institute). The report, funded by GSK, explores the role of social and structural determinants of health in adult vaccine access and uptake across five global cities with strong data about their aging populations: Bangkok, Thailand; Brussels, Belgium; Chicago, US; Manchester, United Kingdom; and New York City, US.